Literature DB >> 10738858

Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder.

K Melkersson1, A L Hulting.   

Abstract

Three patients with psychoses and concomitant prolactin-secreting pituitary tumours are described. Patients A and B had bipolar and schizoaffective disorders, respectively. They had both been treated with neuroleptics for 20 years before the prolactinomas were revealed. Patient C developed a paranoid psychosis after two years of continuous bromocriptine treatment for a pituitary tumour. In patient A the prolactin level was successfully normalized and a good antipsychotic effect was maintained by combined therapy with haloperidol and quinagolide but not bromocriptine. In patient B the prolactinoma was removed by surgery, in view of the serious nature of the psychotic disorder, to avoid psychotic relapse by treatment with a dopamine agonist. In patient C a good result was obtained with the combination of clozapine and bromocriptine. These case reports support the view that neuroleptics being dopamine antagonists and dopamine agonistic agents which are the primary treatment of prolactinomas can cancel out each other's effects. The combination of clozapine and quinagolide is recommended as the treatment of choice for most patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738858     DOI: 10.1007/pl00007539

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  7 in total

1.  Cognitive and perceptual disturbances in a young man.

Authors:  Janos Zahajszky; Davin K Quinn; Felicia A Smith; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 2.  Management of psychosis associated with a prolactinoma: case report and review of the literature.

Authors:  Shirin Ali; Karen Klahr Miller; Oliver Freudenreich
Journal:  Psychosomatics       Date:  2010 Sep-Oct       Impact factor: 2.386

3.  National trends in hospital readmission following transsphenoidal surgery for pituitary lesions.

Authors:  Kelly A Shaftel; Tyler S Cole; Andrew S Little
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

4.  New insights in the management of antipsychotics in the treatment of schizophrenia in a patient with prolactinoma: a case report and review of the literature.

Authors:  Elvis Henrique Santos Andrade; Pedro Mario Pan; Paula F Ramalho da Silva; Ary Gadelha
Journal:  Case Rep Med       Date:  2010-11-10

5.  Treatment complexities of a young woman suffering psychosis and pituitary adenoma.

Authors:  Maxine Sigman; Kate Drury
Journal:  Case Rep Psychiatry       Date:  2011-11-02

Review 6.  Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.

Authors:  Marco Solmi; Andrea Murru; Isabella Pacchiarotti; Juan Undurraga; Nicola Veronese; Michele Fornaro; Brendon Stubbs; Francesco Monaco; Eduard Vieta; Mary V Seeman; Christoph U Correll; André F Carvalho
Journal:  Ther Clin Risk Manag       Date:  2017-06-29       Impact factor: 2.423

Review 7.  Neuropsychiatric and metabolic aspects of dopaminergic therapy: perspectives from an endocrinologist and a psychiatrist.

Authors:  Anastasia P Athanasoulia-Kaspar; Kathrin H Popp; Gunter Karl Stalla
Journal:  Endocr Connect       Date:  2018-01-29       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.